Patents by Inventor Deborah J. Good

Deborah J. Good has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONJUGATED LINOLEIC ACID SUPPLEMENTATION FOR DISEASE TREATMENT
    Publication number: 20240238237
    Abstract: Described in certain example embodiments herein are methods of and compositions for treating a Snordl l6 deficiency disease or symptom thereof with conjugated linoleic acid (CLA) or a formulation thereof. In some embodiments, the Snordl l6 deficiency disease is Prader-Willi Syndrome. Described in certain example embodiments herein are methods of and compositions for treating Nhlh2 associated hypogonadism with CLA or a formulation thereof.
    Type: Application
    Filed: May 4, 2022
    Publication date: July 18, 2024
    Inventor: Deborah J. Good
  • Prion-free transgenic ungulates
    Publication number: 20100024047
    Abstract: Transgenic and cloned ungulates and particularly cloned cattle are disclosed, wherein such cattle contain a deletion or disruption of the prion gene locus and do not express functional prion protein, and are not susceptible to prion-related diseases such as bovine spongiform encephalopy or Mad Cow Disease.
    Type: Application
    Filed: July 9, 2007
    Publication date: January 28, 2010
    Inventors: Deborah J. Good, Jose Cibelli
  • Prion-free transgenic ungulates
    Publication number: 20020069423
    Abstract: Transgenic and cloned ungulates and particularly cloned cattle are disclosed, wherein such cattle contain a deletion or disruption of the prion gene locus and do not express functional prion protein, and are not susceptible to prion-related diseases such as bovine spongiform encephalopy or Mad Cow Disease.
    Type: Application
    Filed: March 26, 2001
    Publication date: June 6, 2002
    Inventors: Deborah J. Good, Jose Cibelli
  • Method of inhibiting angiogenesis of tumors
    Patent number: 5192744
    Abstract: A method of inhibiting angiogenesis and preparations for use therein are disclosed. The preparations comprise human thrombospondin in trimer or monomer form or a fragment thereof capable of inhibiting vascularization. The method and preparations are especially applicable to the treatment of solid tumors including skin cancers for controlling tumor neovascularization and thereby arresting tumor enlargement.
    Type: Grant
    Filed: January 12, 1990
    Date of Patent: March 9, 1993
    Assignee: Northwestern University
    Inventors: Noel P. Bouck, Peter J. Polverini, Deborah J. Good, Farzan Rastinejad